Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
Mr. Robert Davis 2014 'den beri şirketle birlikte olan Merck & Co Inc 'in Chairman of the Board 'ıdır.
MRK hissesinin fiyat performansı nasıl?
MRK 'in mevcut fiyatı $115.68 'dir, son işlem günde 0% arttırılmış etti.
Merck & Co Inc için ana iş temaları veya sektörler nelerdir?
Merck & Co Inc Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Merck & Co Inc 'in piyasa değerlemesi nedir?
Merck & Co Inc 'in mevcut piyasa değerlemesi $286.0B 'dir
Merck & Co Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 30 analist Merck & Co Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 7 güçlü al, 12 al, 14 tut, 0 sat ve 7 güçlü sat içermektedir